What is the ticker symbol for IN8bio?

IN8bio trades under the ticker INAB on NASDAQ.

What sector does IN8bio operate in?

IN8bio is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze INAB in a portfolio?

PortView shows INAB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

IN8bio (INAB) Stock Analysis

NASDAQHealthcareBiotechnology

$1.10+0.92%

1-year price historyRange $0.96 – $2.59

52-week range$1.10

$0.88$2.73

What IN8bio does

IN8bio, Inc. is a biotechnology firm currently in the clinical trial phase, dedicated to identifying, advancing, and bringing to market gamma-delta T cell-based treatments specifically for various forms of cancer. The company's primary therapeutic asset, INB-200, is an autologous (patient-derived) gamma-delta T cell product that has been genetically engineered and is presently undergoing a Phase I clinical study for glioblastoma and other solid tumor malignancies. Additionally, INB-100, an allogeneic (donor-derived) candidate, is also in a Phase I clinical trial, aiming to treat acute leukemia patients undergoing hematopoietic stem cell transplantation. Further development includes preclinical programs, INB-400 and INB-300, which are designed to address a range of solid tumor cancers. Established in 2016, the company initially operated as Incysus Therapeutics, Inc. before changing its name to IN8bio, Inc. in August 2020. Its corporate headquarters are located in New York, New York.

Key metrics

Market cap

$10.55M

P/E (TTM)

-0.68

EPS (TTM)

$-1.62

Beta

0.28

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.21

200-day avg

$1.61

52-week high

$2.73

52-week low

$0.88

CEO

William T.

ETFs linked to INAB

Broad-market and Healthcare sector ETFs an investor holding IN8bio is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how INAB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze INAB in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for IN8bio?: IN8bio trades under the ticker INAB on NASDAQ.
Which exchange is INAB listed on?: INAB is listed on NASDAQ.
What sector does IN8bio operate in?: IN8bio is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze INAB in a portfolio?: PortView shows INAB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.